Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment (NCT02243592)
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
🩺 Plain-English Summary (8th-Grade Level)
This pilot research trial studies molecular profiling in tissue samples from patients with cancer who got better with treatment that didn't work for most other patients with the same disease. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to how well patients respond to treatment.
Who can join: Review the eligibility criteria below.
Location: City of Hope Comprehensive Cancer Center — Duarte, California
Age range: 18 Years
🧪 Interventions in This Study
- Laboratory Biomarker Analysis (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (73 Sites)
Showing the first 25 of 73 sites.
- City of Hope Comprehensive Cancer Center — Duarte, California
- Kaiser Permanente-Fresno — Fresno, California
- Kaiser Permanente-Oakland — Oakland, California
- Kaiser Permanente-Richmond — Richmond, California
- UCSF Medical Center-Mission Bay — San Francisco, California
- Kaiser Permanente Medical Center - Santa Clara — Santa Clara, California
- Kaiser Permanente-Santa Rosa — Santa Rosa, California
- Kaiser Permanente-Stockton — Stockton, California
- Kaiser Permanente-Walnut Creek — Walnut Creek, California
- UCHealth University of Colorado Hospital — Aurora, Colorado
- Poudre Valley Hospital — Fort Collins, Colorado
- Greenwich Hospital — Greenwich, Connecticut
- Helen F Graham Cancer Center — Newark, Delaware
- Medical Oncology Hematology Consultants PA — Newark, Delaware
- Sibley Memorial Hospital — Washington D.C., District of Columbia
- Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
- John B Amos Cancer Center — Columbus, Georgia
- South Georgia Medical Center/Pearlman Cancer Center — Valdosta, Georgia
- Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho
- Rush MD Anderson Cancer Center — Chicago, Illinois
- Presence Resurrection Medical Center — Chicago, Illinois
- Cancer Care Specialists of Illinois - Decatur — Decatur, Illinois
- Decatur Memorial Hospital — Decatur, Illinois
- NorthShore University HealthSystem-Evanston Hospital — Evanston, Illinois
- Illinois CancerCare-Peoria — Peoria, Illinois
📞 Contact the Study Coordinator
Phone: (800) 826-4673
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Neoplasm
- Reproductive Health Program in Patients With Cancer — Jonesboro, Arkansas
- rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy — Houston, Texas
- Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer — Newark, Delaware
- Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families — Houston, Texas
- Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies — Los Angeles, California
Explore by condition: All Malignant Neoplasm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.